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Abstract
Background: Longitudinal data sources, such as electronic health records (EHRs), are very valuable for monitoring
adverse drug events (ADEs). However, ADEs are heavily under-reported in EHRs. Using machine learning algorithms
to automatically detect patients that should have had ADEs reported in their health records is an efficient and
effective solution. One of the challenges to that end is how to take into account the temporality of clinical events,
which are time stamped in EHRs, and providing these as features for machine learning algorithms to exploit. Previous
research on this topic suggests that representing EHR data as a bag of temporally weighted clinical events is
promising; however, the weights were in that case pre-assigned according to their time stamps, which is limited and
potentially less accurate. This study therefore focuses on how to learn weights that effectively take into account the
temporality and importance of clinical events for ADE detection.
Methods: Variable importance obtained from the random forest learning algorithm is used for extracting temporal
weights. Two strategies are proposed for applying the learned weights: weighted aggregation and weighted
sampling. The first strategy aggregates the weighted clinical events from different time windows to form new
features; the second strategy retains the original features but samples them by using their weights as probabilities
when building each tree in the forest. The predictive performance of random forest models using the learned weights
with the two strategies is compared to using pre-assigned weights. In addition, to assess the sensitivity of the
weight-learning procedure, weights from different granularity levels are evaluated and compared.
Results: In the weighted sampling strategy, using learned weights significantly improves the predictive performance,
in comparison to using pre-assigned weights; however, there is no significant difference between them in the
weighted aggregation strategy. Moreover, the granularity of the weight learning procedure has a significant impact
on the former, but not on the latter.
Conclusions: Learning temporal weights is significantly beneficial in terms of predictive performance with the
weighted sampling strategy. Moreover, weighted aggregation generally diminishes the impact of temporal weighting
of the clinical events, irrespective of whether the weights are pre-assigned or learned.
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Background
Adverse drug events (ADEs) have become a major public
health problem by causing approximately 2.4 to 12.0 per-
cent of hospital admissions worldwide [1–3]. To improve
drug safety, a wide range of data sources have been used
[4], among which electronic health records (EHRs) are
an especially valuable source of information [5, 6]. It is
not only because EHR data provides a holistic perspec-
tive of patients’ health history, including diagnoses, drug
admissions, laboratory tests and so on; they also contain
longitudinal data over a long time period across a large
population. Nevertheless, ADEs are still under-reported
in EHRs [7]. Manually screeningmillions of health records
to identify ADEs is practically impossible for the mas-
sive amounts of data archived in an EHR database. To
mitigate this problem, supervised machine learning can
be adopted to automatically detect the presence of an
ADE in health records in which it was not but should
have been reported [8–14]. To that end, predictive mod-
els are trained to detect health records that contain ADEs
with clinical events – i.e., diagnoses, drugs, clinical mea-
surements, etc. – as features. These clinical events are
reported in a chronological order in EHRs and the same
event often appears in the same health record several
times at different time points.
One of the advantages of using longitudinal data, such
as EHRs, is that clinical events are recorded chrono-
logically. As a result, temporality can be included as a
parameter when building predictive models from this
data, which is especially important for tasks like iden-
tifying ADEs. There have been attempts to handle the
temporality of clinical events when fitting machine learn-
ing models to EHR data. Examples include Singh et al.
[15] using EHRs to predict kidney function loss and
Zhao et al. [16] identifying ADEs in EHR data. The for-
mer proposed the Stacked-Temporal strategy that divides
patients’ medical history into a number of time windows
and then merges the clinical events within each time win-
dow; this was likewise, but independently, proposed in
the latter study, in which the strategy was denoted Bag of
Binned Events. The disadvantage of this strategy is that the
dimensionality of the feature increases almost proportion-
ally with the number of time windows. Singh et al. [15]
proposed an additional strategy to handle temporality,
calledMultitask-Temporal, that creates a predictive model
using clinical events from each time window and aggre-
gates the outcomes from each task. Meanwhile, Zhao
et al. [16] proposed a strategy, called Bag of Weighted
Events, that assigns weights to clinical events from dif-
ferent time windows and then aggregates the weighted
events. Both studies use aggregation of clinical events
at different time points and compare their strategy to a
baseline which does not take temporality into account,
and both have shown improved predictive performance
when incorporating temporal information in the medical
history of patients. However, in the Multitask-Temporal
strategy, the predictive task is divided into a set of parallel
tasks focusing on each time window, and, consequently,
models the relationship between the target event, in their
case kidney function loss, and clinical events from dif-
ferent time windows independently. Tackling tasks like
ADE detection requires the ability to take into account all
events from the medical history of patients since an ADE
could be the result of a combination of clinical events at
different time points. This is especially true for chronic
or dose-dependent ADEs. Therefore, the Bag of Weighted
Events strategy is advantageous in that it assigns tempo-
ral weights to clinical events from different time windows
accordingly, and hence it not only takes into account the
whole medical history but also incorporates the temporal-
ity of clinical events in the predictive models.
As a continuation of the Bag ofWeighted Events strategy,
another study [17] explored and evaluates various weight-
ing strategies based on the temporality of clinical events in
EHRs. Those strategies, however, obtain weights accord-
ing to each clinical event’s time stamp in relation to the
target event; hence each clinical event receives a weight
that is calculated globally in the same way as the oth-
ers, regardless of differences in terms of informativeness.
For example, body temperature that is measured one day
before the target event, diagnosis of hypotension, receives
a higher weight compared to blood pressure from three
days ago, even if the latter is considered more important
in the model for predicting drug induced hypotension.
Therefore, it is natural not only to weight a clinical event
based on its temporality, but also, to take into account
its importance in predicting the target event. This study
aims to enable learning weights locally for each clinical
event at each time point and evaluate their impact on the
performance of predictive models for ADE detection in
EHRs.
Methods
Here, we first introduce the concept of temporal weight-
ing from previous research; we then describe how such
weights can be learned automatically. Once the tem-
poral weights are obtained, two strategies for applying
them in the predictive modeling procedure are presented.
To evaluate their impact on predictive performance, a
series of experiments are designed using random for-
est as the supervised machine learning algorithm. The
experiments are conducted on 19 datasets, each one cor-
responding to a specific ADE, that are extracted from
the Stockholm EPR Corpus, a Swedish EHR database.
For each patient, a health record of 90 days before the
target ADE is analyzed. To assess the predictive per-
formance of random forest models using different tem-
poral weighting strategies, accuracy, area under ROC
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curve (AUC) and area under the precision and recall
curve (AUPRC) are used. Finally, the granularity of the
weight learning procedure is explored in order to gain
more evidence on the sensitivity of the weights learning
scheme.
Temporal weighting strategies
Temporal weighting of clinical events aims to assign a
weight to each event that takes into account the tem-
porality of this event. The assigned weight will be used
to build predictive models that exploit the correspond-
ing clinical event as a feature. In the previous study [17],
a temporal weighting strategy follows such a form: for a
clinical event that occurred n days prior to the occur-
rence of an ADE, weight w is assigned according to
a curve function f (n). Nine different temporal weight-
ing strategies were proposed in that study, all of which
follow the common underlying assumption: events that
occur closer to the target ADE are more important, in
terms of their informativeness in the predictive models,
and should hence receive more weight than those that
occurred a longer time before the target ADE. There-
fore, events that occurred in the same day as the target
ADE receive a weight of 1, the highest weight; the weight
then decreases monotonically with the number of days
between the corresponding event and the target ADE until
90 days. Ninety days was chosen arbitrarily with common
sense, i.e., the drugs or other clinical events that occurred
more than 3 months before the occurrence of an ADE
were considered unlikely to make significant contribution.
All assigned weights are between 0 and 1. It was observed
in that study that the impact of applying different tempo-
ral weighting strategies is significant; among the proposed
strategies, the best predictive performance is obtained
from assigning weights according to a reciprocal function
of n, as follows:
w = f (n) = 1n (1)
Learning weights automatically
Learning weights automatically is, in this study, per-
formed with the assumption that more informative clini-
cal events should receive higher weights, in contrast to the
pre-assigned weights where more recent clinical events
receive higher weights. Estimation of the informativeness
of clinical events with different time stamps can, naturally,
be achieved by treating each clinical event from a par-
ticular time window as a separate feature, i.e., the Bag of
Binned Events strategy in [16].
Here, we divide 90 days of the patient medical history
before the target ADE event into 12 time windows, which
are 1, 2, 3, 4, 5, 6, 7, 14, 21, 30, 60, 90 days before the tar-
get ADE event, excluding events from the previous time
window. Therefore, the same clinical events from different
time windows are treated as different features. Weights
learning is then achieved by building predictive models
using features from all 12 time windows and extracting
weights in accordance with the informativeness of the fea-
tures. In this study, this is done by calculating variable
importance with the random forest algorithm [18], the
variable importance is estimated using Gini score, which
tests the impurity of each feature as a splitting node in
the tree. The details of the random forest algorithm and
variable importance is described later in Experimental
Setup.
Once the weights of the clinical events have been
obtained, the question moves on to how one can make
use of them when building the predictive model. Here,
we explore and evaluate the following two strategies for
applying the learned temporal weights, which, together
with the learning weights scheme, are illustrated in Fig. 1.
• Weighted Aggregation – corresponding weights are
applied to the value of each event from different time
windows and then the weighted values of the same
event are aggregated.
• Weighted Sampling – weights are used as
probabilities with which features are sampled to be
considered as possible splitting nodes in the random
forest algorithm.
The first strategy is a natural extension of previous
studies [16, 17], while the second strategy is inspired by
previous work on enriched random forest [19]. Although
the random forest algorithm has been proven to be robust,
especially in handling high dimensional data, predictive
performance of the traditional random forest algorithm
seems to degrade when working on high dimensional data
but with a low proportion of truly informative features
[19]. Such a situation typically occurs in gene expression
data and longitudinal healthcare data. Here, for example,
we extract all of the clinical events in the medical his-
tory of patients and use them as features describing each
patient; however, it is not hard to imagine that a patient
could have visited the hospital for various reasons, not all
of which is related to the target ADE. In this case, among
the large number of clinical events, only a small portion of
them might be informative for predicting the target ADE.
When the proportion of such non-informative features is
large, it is almost certain that each tree in the forest would
be built on at least one non-informative feature. Thus the
average quality of each tree declines, and consequently
results in a less robust forest. Thismethod has been shown
to be better than pre-filtering out the non-informative
features on genome expression data [19]. Normally, fea-
tures have an equal chance to be selected when building
each tree in the forest; here, more important features
have a higher chance to be selected. In this case, we use
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Fig. 1 Learning temporal weights of clinical events from electronic health records
the learned weight for each feature as the probability of
it being selected. Doing so allows us to avoid aggregat-
ing features from different time windows and to model
their importance accordingly. It also allows us to take
into account possible interactions between the same event
from different time windows (see Algorithm 1).
Algorithm 1Weighted Sampling Strategy
Given data D with N features
Build random forest on D to obtain variable importance
of each variableWn
NormalizeWn to obtain Pn
for i = 1 to ntree do
Randomly sample D with replacement to create Di
Select Ni =
√
N features with probability Pn as
possible splitting feature
Build decision tree on Di and Ni
end for
Granularity of weight learning
The temporal weights learned from the above scheme are
specific for each individual event from each time window.
To obtain insights into this scheme, in terms of sensitiv-
ity, i.e., how the predictive model’s performance would be
influenced if the learned weights were from a different
level of specificity, we also explored the granularity of the
weight learning.More specifically, we would like to under-
stand whether the impact of temporality varies only with
the temporal information or if it is also influenced by the
event types and even particular events of the same type.
Here, three levels of specificity of weight learning were
investigated:
• Per time window: a unique weight is learnt for all
events in the same time window.
• Per event type in each time window: a unique weight
is learnt for each event type (i.e., diagnosis, drug and
clinical measurement) in the same time window.
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• Per individual event: a unique weight is learnt for
each individual event from each event type in each
time window.
Data source
In this study, 19 datasets were extracted from a real EHR
system – the Stockholm EPR Corpus [20]. This research
has been approved by the Regional Ethical Review Board
in Stockholm (permission number 2012/834-31/5). This
database contains health records from about 1.2 mil-
lion patients over 7 years (2009–2015), which were col-
lected from Karolinska University Hospital in Stockholm,
Sweden. This database consists of heterogeneous types of
information, including 11,623 unique diagnoses (encoded
by ICD-10, the 10th revision of the International Sta-
tistical Classification of Diseases and Related Health
Problems), 1,564 unique drugs (encoded by ATC,
Anatomical Therapeutic Chemical Classification System),
1,877 unique clinical measurements from laboratory tests
and millions of clinical notes in free-text. Here, we focus
on the use of structured information, i.e., diagnoses,
drugs and clinical measurements.
A previous study [21] has categorized ICD-10 diagnosis
codes in terms of how they are used for indicating ADEs
during hospital admissions, among which category A.1
(a drug-related causation was noted in the diagnosis code)
and category A.2 (a drug- or other substance-related cau-
sation was noted in the diagnosis code) indicate a clear
sign of ADE occurrence; hence the most frequent, at least
assigned to 50 patients, A.1 and A.2 ADE-related diag-
nosis codes in the Stockholm EPR Corpus were selected.
In total, 19 datasets were extracted with the existence of
an ADE-related diagnosis code as the class label in each
dataset. The task here is to detect patients who should,
but do not, have a specific ADE reported in their health
records, which results in a binary classification task.
In each dataset, positive examples are patients whom
have been assigned an ADE-specific diagnosis code and
negative examples are patients whom have been assigned
a similar code (defined as two codes sharing the same first
three levels of the ICD-10 concept hierarchy) to the cor-
responding ADE-related one. For instance, if the positive
examples are patients diagnosedwith I95.2 (Drug-induced
hypotension), the negative examples are patients diag-
nosed with any code starting with I95 (Hypotension),
but not I95.2. Features are formed from clinical events
including diagnoses, drugs and clinical measurements,
that occurred 90 days before the occurrence of the target
ADE. According to the findings from an earlier study on
representing clinical events in EHRs [8], for each exam-
ple, the value for each clinical event (feature) was the total
number of times that it occurred during the whole or a part
of the patient history up to 90 days. The class label, the
number of positive and negative examples and the number
of clinical events involved in each dataset are described in
Table 1.
Experimental setup
A series of experiments were conducted to evaluate the
impact of learning weights of clinical events for predicting
ADEs. First, we evaluated the predictive models using the
learned temporal weights from the two proposed strate-
gies, in comparison to using the pre-assigned weights,
calculated as in Eq. 1.
In a follow-up experiment, in order to investigate how
the learned weights influence the predictive performance
in terms of tree quality and diversity, the average tree per-
formance was compared to the ensemble performance,
which provides some insight into the ensemble classifiers.
In an ensemble model, such as random forest used in this
study, there are two components that affect the predictive
performance: the performance of each individual model
(tree in the case of random forest) and to what extent the
models vary in their predictions (often referred to as diver-
sity [22]). In a regression framework, it is suggested that
diversity can be estimated as the difference between the
(squared) error of the ensemble and the average (squared)
error of the ensemble members [23]. The above states
that the ensemble error can be no higher than the aver-
age model error, and the more diversity, the lower the
ensemble error. Currently, there is no standard for how to
estimate diversity in a classification framework; here we
adopt the idea from the regression framework, estimating
the diversity as the difference between average tree per-
formance and the ensemble performance in terms of error
rate.
Finally, we explored the granularity of the weight
learning by assigning weights on three specificity levels:
(1) each individual clinical event in each time window
receives a unique weight, denoted as all; (2) clinical events
that belong to one event type in each time window receive
a common weight, denoted as type; (3) all clinical events
in each time window receive a common weight, denoted
as time.
The random forest algorithm [18] was exploited in
all experiments to generate predictive models. Random
forest was chosen mainly for its reputation of being
robust in terms of achieving high accuracy, its ability
to handle high-dimensional data efficiently, as well as
the possibility of obtaining estimates of variable impor-
tance. This algorithm is an ensemble classifier, which
constructs a set of decision trees together voting for
what class label to assign to an example to be classi-
fied. Each tree in the forest is built from a bootstrap
replicate of the original instances, and a subset of all
features is randomly sampled at each node when build-
ing the tree, in both cases to increase diversity among
the trees. With increasing number of trees in the forest,
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Table 1 Datasets description including class label, number of positive examples, number of negative examples and number of related
unique clinical events
ADE Description Positive Negative Events
D611 Drug-induced aplastic anaemia 593 105 2025
D642 Drug-induced secondary sideroblastic anaemia 217 9673 6076
D695 Secondary thrombocytopenia 1246 2148 4134
E273 Drug-induced adrenocortical insufficiency 70 259 1601
G620 Drug-induced polyneuropathy 96 783 2448
I952 Drug-induced hypotension 115 1287 2933
L270 Drug-induced generalized skin eruption 182 468 2480
L271 Drug-induced localized skin eruption 151 498 2481
M804 Drug-induced osteoporosis with pathological fracture 52 1170 2208
M814 Drug-induced osteoporosis 57 5097 4158
O355 Maternal care for damage to fetus by drugs 146 260 1277
R502 Drug-induced fever 80 6434 5151
T782 Adverse effects: anaphylactic shock 131 856 2639
T783 Adverse effects: angioneurotic oedema 283 720 2639
T784 Adverse effects: allergy 574 415 2635
T801 Vascular complications following infusion, transfusion and therapeutic injection 66 609 2063
T808 Other complications following infusion, transfusion and therapeutic injection 538 138 2060
T886 Drug-induced anaphylactic shock 89 1506 3765
T887 Unspecified adverse effect of drug or medicament 1047 550 3770
the probability that a majority of trees makes an error
decreases, given that the trees perform better than ran-
dom and that the errors are made independently. The
algorithm has often been shown in practice to result in
state-of-the-art predictive performance, though this con-
dition can only be guaranteed in theory. In this study,
each random forest consisted of 500 trees. Another advan-
tage of the random forest algorithm is that it produces
variable importance, which can be estimated in differ-
ent ways, see, e.g., [18]. In this study, Gini importance
[24] was used as the variable importance metric, where
a high Gini importance indicates that a variable plays a
greater role in splitting the data into the defined classes.
A Gini importance of zero means that a variable is con-
sidered useless or is never selected to build any tree in the
forest.
The generated predictive models were evaluated via
stratified 5-fold cross validation with 2 iterations. Perfor-
mance evaluation metrics were accuracy, area under the
ROC curve (AUC) and area under the precision-recall
curve (AUPRC). Accuracy measures the percentage of
correct predictions including both positive and negative
ones. A ROC curve represents the relation between sen-
sitivity (recall) and specificity, where the former measures
how many of the positive examples have been identified
as being positive and the latter measures how many of
the negative examples have been identified as being neg-
ative. AUC depicts the performance of a model without
regard to class distribution or error costs by estimating the
probability that a model ranks a randomly chosen posi-
tive example ahead of a negative one. Both sensitivity and
specificity are irrespective of the actual positive/negative
balance on the test set; therefore, AUC is not biased in the
case of a skewed class distribution. Finally, AUPRC repre-
sents the relation between precision and recall, depicting
the probability that precision is higher than recall for each
recall threshold. Since, precision measures how many of
the examples been identified as being positive are true
positive, and hence this score depends on how rare is
the positive class. Therefore, AUPRC is preferred when
the positive class is rare but of greater interest than the
negative class.
When two models were compared to each other, the
Wilcoxon signed-rank test was used to assess the statisti-
cal significance; when there were more than two models
being compared, the Friedman test [25] was employed
for statistical testing of the null hypothesis that all mod-
els perform equally, followed by a post-hoc test using
the Bergmann-Hommel procedure [26] to conduct signif-
icance tests on pair-wise comparisons.
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Results
In this study, the scheme of learning temporal weights
of clinical events, including two ways of applying the
learned weights, i.e., Weighted Aggregation and Weighted
Sampling, was evaluated. The former aggregates the same
clinical event from different time windows in accordance
to the learned weights, while the latter exploits the learned
weights as sampling probabilities of the clinical events
when constructing each tree in the random forest. In
both strategies, the use of learned weights is compared
to the use of pre-assigned weights for each clinical event
based on its time stamp in relation to the target ADE, i.e.,
the number of days between the two events, respectively.
Table 2 lists the results of comparing the predictive perfor-
mance of the Weighted Aggregation strategy by applying
pre-assigned and learned weights on 19 datasets extracted
from an EHR database. It is shown that there is no signif-
icant difference on the impact of pre-assigning weights or
learning weights. Nevertheless, from Table 3, where the
corresponding results of the Weighted Sampling strategy
are presented, we can see that by learning the tempo-
ral weights of clinical events, the predictive performance
is significantly improved on all selected performance
metrics. Especially for accuracy and AUPRC, performance
is enhanced by about 5 % overall and for some datasets,
such as D611, D695 and O355, the improvement is over
10 % on accuracy.
In order to understand why the learned weights in the
weighted sampling leads to significant improved perfor-
mance compared to the pre-assigned weights, we com-
pared the average tree performance and the ensemble
(forest) performance for each of them. Figure 2 shows the
error rates of average tree and ensemble of all the pro-
posed weighting strategies in this study. It is obvious that
using learned weights in the weighted sampling (LWS)
leads to the strongest trees and consequently the best
ensemble, given its lowest error rate. Moreover, if we com-
pare the difference between the average tree performance
and the ensemble performance for each of the weight-
ing strategies, both strategies using learned weights yield
bigger differences than using pre-assigned weights. It is
interesting to note that, in the weighted aggregation strat-
egy, the ensemble performance when using preassigned
weights (PWS) is comparable to using learned weights
(LWA), even if the average tree quality is higher in the
former.
Table 2 Predictive performance of models using pre-assigned (P) or learned (L) weights in the weighted aggregation (WA) strategy
Accuracy AUC AUPRC
ADE PWA LWA PWA LWA PWA LWA
D611 76.46 76.68 0.882 0.882 0.956 0.954
D642 97.79 97.79 0.973 0.965 0.750 0.688
D695 76.28 76.69 0.863 0.872 0.771 0.768
E273 81.77 81.78 0.681 0.669 0.309 0.323
G620 91.64 91.64 0.809 0.803 0.316 0.326
I952 91.71 91.71 0.583 0.564 0.110 0.107
L270 73.07 72.12 0.847 0.841 0.807 0.793
L271 84.18 84.18 0.774 0.735 0.386 0.342
M804 95.17 95.17 0.652 0.615 0.098 0.075
M814 98.71 98.71 0.732 0.740 0.040 0.050
O355 72.24 71.55 0.978 0.980 0.934 0.942
R502 99.16 99.16 0.800 0.776 0.218 0.168
T782 94.81 94.81 0.712 0.700 0.156 0.152
T783 83.33 83.33 0.749 0.758 0.362 0.363
T784 66.15 66.15 0.734 0.741 0.809 0.811
T801 90.35 90.35 0.891 0.892 0.493 0.458
T808 77.93 77.72 0.882 0.879 0.958 0.958
T886 94.95 94.95 0.689 0.692 0.117 0.109
T887 61.35 60.97 0.751 0.752 0.776 0.773
Average 84.58 84.50 0.788 0.782 0.493 0.482
p-value 0.2936 0.1564 0.08743
Bold indicates winning
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Table 3 Predictive performance of models using pre-assigned (P) or learned (L) weights in the weighted sampling (WS) strategy
Accuracy AUC AUPRC
ADE PWS LWS PWS LWS PWS LWS
D611 76.46 90.38 0.887 0.946 0.949 0.981
D642 97.79 99.47 0.979 0.983 0.814 0.936
D695 71.10 87.74 0.895 0.923 0.806 0.881
E273 81.78 79.92 0.615 0.650 0.264 0.272
G620 91.64 92.22 0.815 0.837 0.334 0.441
I952 91.71 91.64 0.557 0.554 0.116 0.118
L270 67.14 73.07 0.843 0.828 0.791 0.795
L271 84.18 85.22 0.753 0.759 0.356 0.406
M804 95.17 95.12 0.571 0.598 0.072 0.079
M814 98.71 98.69 0.702 0.722 0.039 0.052
O355 82.13 96.49 0.980 0.989 0.948 0.977
R502 99.16 99.22 0.840 0.774 0.148 0.280
T782 94.81 94.86 0.741 0.754 0.188 0.255
T783 83.33 86.16 0.771 0.788 0.393 0.524
T784 66.86 75.46 0.762 0.761 0.830 0.829
T801 90.35 93.55 0.868 0.880 0.533 0.635
T808 77.93 84.38 0.869 0.879 0.954 0.954
T886 94.95 94.86 0.741 0.738 0.159 0.190
T887 60.19 69.72 0.762 0.771 0.765 0.802
Average 84.49 88.85 0.787 0.797 0.498 0.548
p-value 0.002838 0.01597 0.00001907
Bold indicates winning
In the last experiment, we investigated the impact of
the granularity of temporal weights learning, where three
specificity levels were evaluated: (1) weights learned on a
time-window level; (2) weights learned on an event-type
level within each time window; and (3) weights learned
on an individual level from each event type within each
time window. Comparing the predictive performance of
models exploiting weights from these three specificity lev-
els in Fig. 3, we can see that the choice of specificity
level has a significant impact on the predictive perfor-
mance in the Weighted Sampling strategy, but no such
significance is observed in the Weighted Aggregation
strategy.
The post-hoc analysis through the Bergmann-Hommel
procedure, as shown in Table 4, indicates that, overall,
learning weights on each individual clinical event level
(all) yields better performance compared to the other two
more general levels; learning weights on each individual
clinical event level (all) leads to significantly improved
accuracy and AUPRC compared to learning weights per
event type from each time window (type); the difference
between learning weights per event type and per time
window is almost negligible.
Discussion
This study evaluated the impact of learning temporal
weights of clinical events, which was applied through
two strategies, weighted aggregation and weighted sam-
pling, in electronic health records for adverse drug event
detection. The evaluation was done by exploiting these




















Fig. 2 Error rates of average tree versus ensemble of the weighted
aggregation (WA) and weighted sampling (WS) strategy using
pre-assigned (P) and learned (L) weights respectively





























































































Fig. 3 Compare weights learned on different specificity levels in terms of predictive performance. Green indicates a significant difference and red
indicates no significance. P-values are obtained via a Friedman test
strategies to generate features on 19 datasets extracted
from an EHR database. The results show that in the
weighted sampling strategy, using learned weights signifi-
cantly improves the predictive performance compared to
using pre-assigned weights; however, there is no signifi-
cant difference between them in the weighted aggregation
strategy. One explanation for the latter could be the high
sparsity of the data. All of the 19 datasets in this study
are of high dimensionality and sparsity due to the fact
that most clinical events only occurred to a small group of
patients, i.e., the vast majority of the examples for a given
feature have a value of zero. For features with only one or
very few non-zero values, the impact of applying differ-
ent weighting strategies is almost negligible, even though
some of these features might be valuable indicators. To
be more specific, if a feature has only one or a few non-
zero values, when using it as an indicator to classify the
examples, it does not matter whether these small numbers
Table 4 Post-hoc analysis results of significance testing on pair-wised comparisons among different weights specificity levels in the
weighted sampling strategy
Accuracy AUC AUPRC
ADE all type time all type time all type time
all – 0.052 0.045 – 0.028 0.746 – 0.002 0.144
type – – 0.626 – – 0.028 – – 0.052
Ave. Rank 1.53 2.16 2.32 1.68 2.53 1.79 1.47 2.58 1.95
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of non-zero values are weighted or not since they will
most likely be distinguished against all the zero values; as
a result, the applied weights will have almost no impact
on the predictive performance. In the weighted aggrega-
tion strategy, the learned weights were embedded in the
feature values, which does not affect the sparsity; there-
fore, for very sparse features, no matter how their weights
change, their contribution to the predictive performance
will not be influenced. However, in the weighted sam-
pling strategy, the learned weights were used as sampling
probabilities, which makes use of the higher weighted, i.e.,
more informative, features more often, so that the weights
have a higher and more direct impact on the predictive
performance.
Besides the difference between the learned weights
and the pre-assigned weights within each strategy, the
weighted sampling strategy only leads to better predic-
tive performance than the weighted aggregation strategy
when using learned weights, i.e., the choice of strategy on
applying the weights matters less with the pre-assigned
weights (given the close results between PWA and PWS).
This indicates that the improved predictive performance
is a result of the combination of learning weights and
application of the weighted sampling strategy. To under-
stand more deeply how the performance is improved,
we looked into the random forest models in terms of
average tree quality and diversity. The results in Fig. 2
indicates that using learned weights in the weighted sam-
pling strategy yields the best predictive performance due
both to better individual tree quality and larger diver-
sity. Moreover, learning weights also contributes to bigger
diversity in the weighted aggregation strategy. Compar-
ing learning weights in both the weighted aggregation
(LWA) and weighted sampling (LWS) strategy, it seems
that the latter does not result in a lower diversity as one
would have expected, given that, there, the important fea-
tures appear in many trees. It is probably due to the high
dimensionality of all the datasets and, more importantly,
an indication that a really small portion of features are
relevant/important; hence, even though this small num-
ber of important features appear in many trees, the diver-
sity is still maintained by the other features that are
selected to build each tree. Therefore, weighted sampling
using learned weights is particularly beneficial when using
vast amounts of clinical events from EHRs for predictive
modelling, where probably only a small amount of infor-
mation is highly relevant to the predicting target, while the
remaining information is less useful.
Another advantage of learning weights, besides taking
into account the importance of each clinical event, is that
weights can be learned on a more specific level: rather
than just looking at the time window, the specificity can
be adjusted. Concerning the granularity of weights, pre-
assigning weights is equivalent to learning weights per
time window (denoted as time in Fig. 3 and Table 4), both
of which assign the same weight to all clinical events from
the same time window. Here, within a time window, dif-
ferent weights can be learned further for each event type
(denoted as type) – i.e., diagnosis, drug and clinical mea-
surement – or even each individual clinical event within
each event type (denoted as all). Again, the impact of
using weights from different specificity levels yields a sig-
nificant impact only in the weighted sampling strategy, but
not in the weighted aggregation strategy. It is probably a
result of the high dimensionality and sparsity of the data as
argued above. By looking at the post-hoc analysis results
for the pairwise comparisons, we can see that, on one
hand, learning weights for each event type gives the worst
performance, which suggests that there is no evidence
for treating different event types differently; on the other
hand, learning weights for each individual clinical event,
the most specific level, yields the best performance, which
indicates that individual events should not be treated in
the same way. For instance, diagnoses in general shouldn’t
be more or less important than drugs; however, a particu-
lar diagnosis code can bemore important than a particular
drug. It is interesting to note that it is not that more spe-
cific weights learning gives better performance, as one
would expect. Weights on the type level are more specific
than the ones on the time level, but the latter sometimes
outperforms the former.
One limitation of this study is that only one learn-
ing weights algorithm, namely random forest’s variable
importance, is explored. In future work, other methods
are worth investigating; for example, methods that do not
use feedback from a classifier to assign weights but use
a pre-existing model instead, such as information gain.
Further along this line, learning weights here focuses on
temporality and informativeness of the clinical events;
nevertheless, there are also other criteria that can be used
to learn the weights. For example, clinical events are rep-
resented as the number of times that they occur in a
time window, which disallows learning weights based on
event values and/or how sharply an event value changes
over time. This is especially crucial when using clinical
measurements as features.
Conclusion
The temporal information that is embedded in longitudi-
nal healthcare data is very valuable for building predictive
models for pharmacovigilance. Electronic health records
is one of this kind, where clinical events, such as diag-
noses, drug administrations and clinical measurements,
are typically time stamped. Using pre-assigned weights
according to events’ time stamps has been shown to be
an effective way of exploiting temporality in predictive
models. However, pre-assigned weights are limited to
the chronology of clinical events, but fails to take into
Zhao and Henriksson BMCMedical Informatics and DecisionMaking 2016, 16(Suppl 2):71 Page 121 of 162
account their importance, in terms of informativeness,
when building the predictive models. To mitigate this
problem, this study focuses on how to learn the weights
automatically when constructing the predictive models in
a way that reflects both temporality and importance of the
clinical events. To take into account the temporality, each
patient’s medical history is segmented into a set of time
windows and features are extracted from each of them; for
the importance, a random forest model is built using these
extracted features to produce variable importance, which
is then used as the weight for each feature. To apply these
weights, two strategies are proposed: weighted aggrega-
tion and weighted sampling. The former aggregates the
weighted clinical events from different time windows to
form new features, while the latter keeps the original fea-
tures but samples them with their weights as probabilities
when building each tree in the forest. We conclude here
that learning weights is significantly beneficial in terms
of predictive performance in the weighted sampling strat-
egy. Moreover, weighted aggregation generally diminishes
the impact of temporal weighting of the clinical events,
irrespective of whether the weights are pre-assigned or
learned.
Acknowledgements
This work was partly supported by the project High-Performance Data Mining
for Drug Effect Detection at Stockholm University, funded by Swedish
Foundation for Strategic Research under grant IIS11-0053.
Declarations
Publication costs for this article were funded by the project High-Performance
Data Mining for Drug Effect Detection at Stockholm University. This article has
been published as part of BMCMedical Informatics and DecisionMaking Vol 16
Suppl 2 2016: Selected articles from the IEEE International Conference on
Bioinformatics and Biomedicine 2015: medical informatics and decision




JZ initiated the idea of this study. JZ and AH participated in discussions on the
study design. JZ and AH conducted the experiments. JZ created a draft of the
manuscript. AH commented on the draft. Both authors read and approved the
final manuscript.
Competing interests
The authors declare that they have no competing interests.
Published: 21 July 2016
References
1. Schneeweiss S, Hasford J, Göttler M, Hoffmann A, Riethling AK, Avorn J.
Admissions caused by adverse drug events to internal medicine and
emergency departments in hospitals: a longitudinal population-based
study. Eur J Clin Pharmacol. 2002;58(4):285–91.
2. Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ,
Farrar K, Park BK, Breckenridge AM. Adverse drug reactions as cause of
admission to hospital: prospective analysis of 18 820 patients. BMJ.
2004;329(7456):15–19.
3. Mjörndal T, Boman MD, Hägg S, Bäckström M, Wiholm BE, Wahlin A,
Dahlqvist R. Adverse drug reactions as a cause for admissions to a
department of internal medicine. Pharmacoepidemiol Drug Saf.
2002;11(1):65–72.
4. Härmark L, Van Grootheest A. Pharmacovigilance: methods, recent
developments and future perspectives. Eur J Clin Pharmacol. 2008;64(8):
743–52.
5. Schuemie MJ, Coloma PM, Straatman H, Herings RM, Trifirò G,
Matthews JN, Prieto-Merino D, Molokhia M, Pedersen L, Gini R, et al.
Using electronic health care records for drug safety signal detection: a
comparative evaluation of statistical methods. Med Care. 2012;50(10):
890–7.
6. Harpaz R, Haerian K, Chase HS, Friedman C. Mining electronic health
records for adverse drug effects using regression based methods. In: 1st
ACM International Health Informatics Symposium. ACM; 2010. p. 100–7.
7. Hazell L, Shakir SA. Under-reporting of adverse drug reactions. Drug Saf.
2006;29(5):385–96.
8. Zhao J, Henriksson A, Asker L, Boström H. Detecting adverse drug
events with multiple representations of clinical measurements. In: IEEE
International Conference on Bioinformatics and Biomedicine. IEEE; 2014.
p. 536–43.
9. Zhao J, Henriksson A, Boström H. Detecting adverse drug events using
concept hierarchies of clinical codes. In: IEEE International Conference on
Healthcare Informatics. IEEE; 2014. p. 285–93.
10. Henriksson A, Zhao J, Boström H, Dalianis H. Modeling heterogeneous
clinical sequence data in semantic space for adverse drug event
detection. In: IEEE International Conference on Data Science and
Advanced Analytics. IEEE; 2015.
11. Zhao J, Henriksson A, Boström H. Cascading adverse drug event
detection in electronic health records. In: IEEE International Conference
on Data Science and Advanced Analytics. IEEE; 2015.
12. Henriksson A, Kvist M, Dalianis H, Duneld M. Identifying adverse drug
event information in clinical notes with distributional semantic
representations of context. J Biomed Inform. 2015;57:333–49.
13. Henriksson A. Representing clinical notes for adverse drug event
detection. In: 6th International Workshop on Health Text Mining and
Information Analysis (LOUHI). Association for Computational Linguistics;
2015. p. 152–8.
14. Henriksson A, Zhao J, Boström H, Dalianis H. Modeling electronic health
records in ensembles of semantic spaces for adverse drug event
detection. In: IEEE International Conference on Bioinformatics and
Biomedicine. IEEE; 2015.
15. Singh A, Nadkarni G, Gottesman O, Ellis SB, Bottinger EP, Guttag JV.
Incorporating temporal ehr data in predictive models for risk stratification
of renal function deterioration. J Biomed Inform. 2015;53:220–8.
16. Zhao J, Henriksson A, Kvist M, Asker L, Boström H. Handling temporality
of clinical events for drug safety surveillance. In: American Medical
Informatics Association (AMIA) Annual Symposium. American Medical
Informatics Association; 2015.
17. Zhao J. Temporal weighting of clinical events in electronic health records
for pharmacovigilance. In: IEEE International Conference on
Bioinformatics and Biomedicine (BIBM). IEEE; 2015. p. 375–81.
18. Breiman L. Random forests. Mach Learn. 2001;45(1):5–32.
19. Amaratunga D, Cabrera J, Lee YS. Enriched random forests.
Bioinformatics. 2008;24(18):2010–014.
20. Dalianis H, Hassel M, Henriksson A, Skeppstedt M. Stockholm epr corpus:
a clinical database used to improve health care. In: Swedish Language
Technology Conference; 2012.
21. Stausberg J, Hasford J. Drug-related admissions and hospital-acquired
adverse drug events in germany: a longitudinal analysis from 2003 to
2007 of icd-10-coded routine data. BMC Health Serv Res. 2011;11(1):134.
22. Kuncheva LI, Whitaker CJ. Measures of diversity in classifier ensembles
and their relationship with the ensemble accuracy. Mach Learn.
2003;51(2):181–207.
23. Krogh A, Vedelsby J. Neural network ensembles, cross validation, and
cctive learning. In: Advances in Neural Information Processing Systems.
Cambridge MA: MIT Press; 1995. p. 231–8.
24. Strobl C, Boulesteix AL, Zeileis A, Hothorn T. Bias in random forest
variable importance measures: Illustrations, sources and a solution. BMC
Bioinforma. 2007;8(1):25.
25. Demšar J. Statistical comparisons of classifiers over multiple data sets. J
Mach Learn Res. 2006;7:1–30.
26. Garcia S, Herrera F. An extension on “statistical comparisons of classifiers
over multiple data sets” for all pairwise comparisons. J Mach Learn Res.
2008;9(12):2677–94.
